The Asia Pacificmammography systems market isexpected to reach US$ 652.34million in 2027 from US$ 357.56million in 2019; the market is estimated to grow at a CAGR of 8.0% from 2020 to 2027.
The growth of the market is attributed to the increasing prevalence of breast cancer in women and rise in investments in breast cancer programs. However, the shortage of health infrastructure in low-income countries obstructs the growth of the market to a certain extent.
The widespread presence of breast cancer in the world has resulted in a huge demand for mammography systems for diagnostic purposes. A few of the common symptoms of breast cancer are the appearance of inverted nipples, changes in breast shape, development of lumps in the breast, and red or scaly patch of skin, or sore nipples. The excessive population in China, coupled with the rise of breast cancer prevalence, is majorly driving the growth of the mammography systems market in China, making it a prime market in Asia Pacific. According to the Globocan report, in 2018, China reported ~367,900 new cases of breast cancer and 97,972 deaths due to the disease. Further, as per the Globocanreport, in 2018, Japan experienced ~66,101 new breast cancer cases and 15,452breast cancer deaths.
Considering the geographic and economical operations between Asian countries and China, the countries are expected to witness the challenge of COVID-19. The outbreak of disease has severely affected the tourism industry, lead to supply chain disruptions and problems posed by the shortage of healthcare infrastructure in low-income countries. For preventing the spread of disease, restrictive measures have been taken in South Korea, Malaysia, Singapore, the Philippines, and India. COVID-19 outbreak is expected to have short- and long-term impacts in the region. The healthcare systems in the region are witnessing drastic decline in breast examinations. Furthermore, implementation of social distancing strategies and fear of getting infected by corona virus is also having huge impact on breast examination. This reduction in breast examinations are likely to hamper the market growth.
Based on product, the Asia Pacific mammography systems market is segmented into full field digital mammography systems, breast tomosynthesis systems, and analog systems. Thefull field digital mammographysystemssegment accounted for the largest share in the market in 2019.However, the market for breast tomosynthesis systems is anticipated to grow at the highest CAGR during 2020-2027.
Based on technology, the Asia Pacific mammography systems market, by technology, is segmented into screen film, 2D mammography, 3D mammography, and others. The 2D mammography technology held the largest share of the market in 2019, and it is anticipated to register the highest CAGR during the forecast period.
Based on enduser, the Asia Pacific mammography systems market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2019, and it further estimated to register the highest CAGR during 2020-2027.
A few of the major primary and secondary sources referred to for this report on the Asia Pacific mammography systems market are Globocan, Individual Medical Assistance Program, and Breast Screen Australia.
Reasons to Buy
The growth of the market is attributed to the increasing prevalence of breast cancer in women and rise in investments in breast cancer programs. However, the shortage of health infrastructure in low-income countries obstructs the growth of the market to a certain extent.
The widespread presence of breast cancer in the world has resulted in a huge demand for mammography systems for diagnostic purposes. A few of the common symptoms of breast cancer are the appearance of inverted nipples, changes in breast shape, development of lumps in the breast, and red or scaly patch of skin, or sore nipples. The excessive population in China, coupled with the rise of breast cancer prevalence, is majorly driving the growth of the mammography systems market in China, making it a prime market in Asia Pacific. According to the Globocan report, in 2018, China reported ~367,900 new cases of breast cancer and 97,972 deaths due to the disease. Further, as per the Globocanreport, in 2018, Japan experienced ~66,101 new breast cancer cases and 15,452breast cancer deaths.
Considering the geographic and economical operations between Asian countries and China, the countries are expected to witness the challenge of COVID-19. The outbreak of disease has severely affected the tourism industry, lead to supply chain disruptions and problems posed by the shortage of healthcare infrastructure in low-income countries. For preventing the spread of disease, restrictive measures have been taken in South Korea, Malaysia, Singapore, the Philippines, and India. COVID-19 outbreak is expected to have short- and long-term impacts in the region. The healthcare systems in the region are witnessing drastic decline in breast examinations. Furthermore, implementation of social distancing strategies and fear of getting infected by corona virus is also having huge impact on breast examination. This reduction in breast examinations are likely to hamper the market growth.
Based on product, the Asia Pacific mammography systems market is segmented into full field digital mammography systems, breast tomosynthesis systems, and analog systems. Thefull field digital mammographysystemssegment accounted for the largest share in the market in 2019.However, the market for breast tomosynthesis systems is anticipated to grow at the highest CAGR during 2020-2027.
Based on technology, the Asia Pacific mammography systems market, by technology, is segmented into screen film, 2D mammography, 3D mammography, and others. The 2D mammography technology held the largest share of the market in 2019, and it is anticipated to register the highest CAGR during the forecast period.
Based on enduser, the Asia Pacific mammography systems market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2019, and it further estimated to register the highest CAGR during 2020-2027.
A few of the major primary and secondary sources referred to for this report on the Asia Pacific mammography systems market are Globocan, Individual Medical Assistance Program, and Breast Screen Australia.
Reasons to Buy
- To understand the Asia Pacific mammography systems market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for mammography systems market
- Efficiently plan M&A and partnership deals in Asia Pacific mammography systems market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific mammography systems market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Mammography Systems Market - Market Landscape
5. Asia Pacific Mammography Systems Market - Key Market Dynamics
6. Mammography Systems Market - Asia Pacific Analysis
7. Asia Pacific Mammography Systems Market Analysis and Forecasts To 2027 - By Product
8. Asia Pacific Mammography Systems Market Analysis By Technology
9. Asia Pacific Mammography Systems Market Analysis By End-User
10. Mammography Systems Market Revenue and Forecasts To 2027 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on Asia Pacific Mammography Systems Market
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hologic Inc
- General Electric Company
- Carestream Health Inc
- Siemens Healthineers AG
- Canon Medical Systems
- Fujifilm Corporation
- IMS GIOTTO S.P.A.
- PLANMED OY
- Koninklijke Philips N.V.
